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In brief  
 There is moderate evidence of an association between oral health and two pulmonary 
conditions: chronic obstructive pulmonary disease (COPD) and pneumonia. COPD is 
associated with periodontal disease, while pneumonia is associated with dental caries and the 
presence of oral plaque, with evidence stronger for the latter condition. 
 Moderate evidence suggests that toothbrushing reduces the incidence, duration, and mortality 
associated with pneumonia in community-living and hospital-based patients, but has no effect 
on pneumonia when used alone in ventilated patients. However, studies linking toothbrushing 
to a reduction in mortality advised caution due to possible bias. 
 There is strong evidence that frail populations (such as ventilated, or community-living and 
hospital-based patients) would have a lower incidence of pneumonia after regular oral 
hygiene interventions which include use of chlorhexidine or povidone iodine, with stronger 
evidence supporting chlorhexidine in mouthwash, gel, or other forms. 
 Although evidence suggests that chlorhexidine reduces the incidence of ventilator-associated 
pneumonia, other outcomes such as mortality are not affected in ventilated patients. Further 
research should explore this. 
 
 
 
Abstract 
This paper reports the one of four reviews exploring the relationships between oral health and general 
medical conditions, in order to support teams within Public Health England, health practitioners and 
policymakers. This review aimed to explore the most contemporary evidence on whether poor oral 
health and pulmonary disease occurs in the same individuals or populations, to outline the nature of 
the relationship between these two health outcomes, and to discuss the implication of any findings to 
health services and future research. The work was undertaken by a group comprising consultant 
clinicians from medicine and dentistry, trainees, public health, and academics. The methodology 
involved a streamlined rapid review process and synthesis of the data. The results identified a number 
of systematic reviews of medium to high quality which indicate that there is evidence that oral health 
and oral hygiene habits have an impact on incidence and outcomes of lung diseases, such as 
pneumonia and COPD in people living in the community and in long term care facilities. The findings 
are discussed in relation to the implications for service and future research. 
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Background 
Pulmonary diseases can be broadly divided into lung infections, lung cancer, and those which 
obstruct airflow (chronic obstructive pulmonary disease and asthma). Lung cancer, chronic 
obstructive pulmonary disease (COPD), and lower respiratory tract infections were three of the top six 
causes of years of life lost in England in 2013 (1). COPD and lung cancer are major causes of 
morbidity and mortality throughout the world. Pneumonia occurs in 1-2 individuals per 1000 (2), 
caused over 5% of all deaths for all ages in 2014 (3), and, together with influenza, accounted for the 
second-most hospital bed days in the UK in 2014-2015 (4). 
Pneumonia is an inflammation of the lung, usually caused by infection (5). Three common causes are 
bacteria, viruses, and fungi some of which can colonise the oral cavity and upper airway (6).  It is also 
possible to contract pneumonia by accidentally inhaling a liquid or chemical. People most at risk are 
over 65 or below two years of age, or already have health problems, e.g. mechanically ventilated 
patients with respiratory problems who have an endotracheal tube placed from the oral cavity to the 
trachea to ensure a patent airway. 
Ventilator-associated pneumonia (VAP) is a known complication of mechanical ventilation and defined 
as “serious inflammation of the lung in patients who required the use of pulmonary ventilator"(5). A 
patient may be ventilated for several reasons, primarily when they require critical care in intensive care 
units (ICUs) such as post-cardiac surgery, trauma, neurological or respiratory conditions, and for 
varying time periods. 
Chronic obstructive pulmonary disease is a type of obstructive lung disease characterized by chronically 
poor airflow. The main symptoms include shortness of breath, cough, and sputum. Tobacco smoking is 
the most common cause of COPD, with a number of other factors such as air pollution and genetics 
playing a smaller role (5). It is diagnosed by a combination of clinical judgement, patient factors, and 
spirometry. 
The two most common diseases affecting oral health are dental caries and periodontitis. Dental caries 
(caries) is the localised destruction of susceptible dental hard tissues by acidic by-products from 
bacterial fermentation of dietary carbohydrates (7). Periodontitis is a chronic inflammatory disease 
caused by bacterial infection of the supporting tissues around the teeth (8). Approximately half of all 
adults in the UK are affected by some level of irreversible periodontitis, which increases with age, and 
almost a third have obvious dental decay (9).  
It is suggested that there is biological plausibility for a causal link between pulmonary disease and oral 
health-related to oral disease pathogens aspirated into the pulmonary tissues. In the absence of 
effective oral care, initial plaque formation will occur within forty-eight hours; the composition of the 
oropharyngeal flora becomes more heavily colonised by virulent gram-negative pathogens that, as well 
as leading to oral disease, may be transported to the lungs where they have the potential to cause 
respiratory infections (10). The aim of good mouth care is to maintain oral cleanliness, remove plaque 
and thereby prevent infection (11). Twice daily brushing is recommended to control both periodontal 
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diseases and caries (12); however, the extent to which this may impact on pulmonary disease is 
unclear. In view of the serious outcomes and high prevalence related to both pulmonary and oral 
diseases, the aim of this review is to collate the most contemporary evidence on any links between the 
two. 
 
Methods  
A rapid review methodology was employed to synthesise the evidence from articles published between 
2005 and 2015 that explored the relationship between pulmonary and oral health. A rapid review is a 
synthesis of the most current and best evidence to inform decision-makers (13). It combines elements 
of systematic reviews with a streamlined approach to summarise available evidence in a timely manner. 
Search syntax was developed based on subject knowledge, MeSH terms, and task group agreements 
(Figure 1); followed by duplicate systematic title and abstract searches of three electronic databases: 
Cochrane, PubMed, OVID (Embase, MEDLINE (R), and PsycINFO). Two independent searches were 
carried out: screening papers by abstract, and title, for relevance and duplication.  
Figure 1  
Studies were included if they were either a systematic review and/or meta-analysis, and explored a link 
between pulmonary and oral health. Disagreements between the reviewers and the wider research 
group were resolved by discussion. Papers were excluded for the following reasons: did not mention 
any term related to oral health or pulmonary health; were not available in English or in full text after 
contacting primary authors; or if a more up-to-date review covering the same topics by the same authors 
was found. 
The following information were extracted from each paper: author, year, population studied, oral 
disease/intervention, definitions used, methods, comparison/intervention and controls, outcomes, 
results, authors’ conclusions, quality and quality justification, as shown in data extraction Table 1 (full 
table available on request).  
Table 1 
From a total of 272 papers initially identified based on title and abstract, 35 remained after removal of 
duplicates, title screening and reviewing abstracts for relevance. These papers were examined in full 
and 23 papers were identified as relevant for the rapid review and synthesis of findings. A flow diagram 
of the process is provided in Figure 2. 
Figure 2 
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Papers were reviewed and the following themes identified: association between oral health and 
pulmonary diseases; association of oral health interventions with the onset and outcomes of pneumonia 
in both (i) community-living and non-ventilated hospital-based patients (henceforth referred to simply 
as “community” and “hospital” patients respectively); and (ii) ventilated patients. The majority of 
evidence relates to patients who had difficulty in managing, or were unable to manage, their own oral 
hygiene measures; this included children, older people, patients with dementia, mechanically ventilated 
patients, and patients with functional disabilities and/or critical illness.   
Quality assessment was undertaken for each systematic review. An AMSTAR assessment was carried 
out on all papers with the methodological quality of the review being rated as “High” with a score 
between eleven and eight, “Moderate” between seven and four, and “Low” between four and zero. The 
quality of all papers was also assessed by group discussion to reinforce the conclusion reached by the 
quality score. 
The quality of the selected studies varied. Of the 23 systematic reviews, 13 were deemed to be high 
quality in line with the AMSTAR scoring system, following group discussion. Nine papers were found 
to be of moderate and one of low quality. Common AMSTAR missing points were the inclusion of grey 
literature, the listing of excluded papers with reasons for their exclusion, and the quality assessment 
of the included studies. Quality scores, as well as rationale for these scores, are presented for each 
paper included in this review in the data extraction table (Table 1).  
Within the themes identified by this review, the papers examining oral hygiene interventions in 
ventilated patients were particularly of strong quality (14-25), with all but five systematic reviews (21, 
23, 24, 26, 27) of high quality, while the systematic reviews examining community and hospital 
patients were more mixed with three of high (28-30), and three of moderate quality (31-33). Finally, 
the papers examining a direct association between oral health and pulmonary diseases were all of 
moderate quality (33-35).  
 
Results: evidence synthesis 
This section is reported in two main sections. First, the nature of association between oral and 
pulmonary disease, including whether or not pulmonary disease is more likely in patients with oral 
disease. Second, the evidence that describes studies that have tested the impact of oral hygiene 
measures on pulmonary disease incidence and outcomes. 
A] Association between oral and pulmonary disease 
Overall the literature suggests associations of varying strength between oral health (periodontitis, 
caries, and plaque) and pulmonary disease (COPD and pneumonia). This was demonstrated by the 
increased presence of oral disease, or oral pathogens, in those participants who developed pulmonary 
disease when compared with those who did not. No evidence was discovered regarding any association 
between oral health and the presence of other conditions, notably lung cancer or tuberculosis. In the 
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next sections, evidence of the associations between individual oral diseases and COPD and pneumonia 
are presented. 
I] Periodontitis and COPD 
In the case of periodontitis and COPD, three reviews of moderate methodological quality highlight an 
association between COPD and periodontal disease. The first, by Azarpazhooh and Leake (35), 
provided weak evidence of an association between COPD and periodontal disease, suggesting study 
participants with significantly higher alveolar bone loss (ABL) and loss of clinical attachment had a 
higher risk of COPD than their counterparts. The second review by Sjogren et al. (33), also highlighted 
a weak association between ABL and dental plaque with COPD. And a third by Zeng et al. (34), 
reviewed fourteen observational studies assessing the relationship between COPD and periodontal 
disease and included pooled data stratified to control for smoking and other risk factors associated with 
the two diseases; the stratified results showed an attenuated, but significant, association between 
COPD and periodontal disease (p <0.001).  
 
II] Periodontitis and Pneumonia 
Azarpazhooh and Leake (2006) (35) reviewed five studies that explored the relationship between 
pneumonia and oral health, suggesting that periodontal pathogens in saliva are a potentially important 
risk factor for pneumonia. No evidence was found linking periodontal disease itself with pneumonia. 
 
III] Caries and pneumonia 
The presence of caries was linked to the development of pneumonia in one moderate quality review 
(35), which reported evidence from a nine-year cohort study that decayed teeth (i.e. dental caries) ([OR] 
~1.2 per decayed tooth) and cariogenic bacteria in saliva and plaque ([OR] 4 to 9.6) were associated 
with a higher risk of pneumonia (35).  
IV] Plaque and pneumonia 
Plaque, and its association with pulmonary disease, was examined by one moderate quality review. 
The evidence to support this was mixed with two prospective cohort  studies suggesting that higher 
plaque scores were associated with a previous history of respiratory tract infection, whilst a third found 
no such significant association between pneumonia and plaque scores (35).  
 
In summary, there is moderate evidence to suggest that patients with caries and plaque have a higher 
likelihood of developing pneumonia, and weak evidence suggesting an increased likelihood of people 
with more alveolar bone loss developing COPD than comparable counterparts. 
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B] Effect of oral hygiene interventions on incidence and outcomes of pulmonary disease  
In this section the impact of oral hygiene interventions is reported in two sub-sections: first in relation to 
community or hospital patients; and, second, in relation to ventilated patients. 
 
I] Effect of oral hygiene interventions on incidence and outcomes of pulmonary disease in community 
or hospital patients 
Several reviews described oral hygiene interventions and their impact on incidence, or outcomes, of 
pneumonia in non-ventilated patients in community or hospital environments, while no evidence was 
found regarding any other pulmonary disease (including COPD). Therefore, this section will solely deal 
with oral hygiene inventions and their effects on pneumonia. These interventions include the use of 
chlorhexidine with concentrations between 0.12 to 2.0%, povidone iodine, the cleaning of prostheses, 
and mechanical interventions such as toothbrushing or professional care involving scaling and 
polishing.  
a) Incidence of pneumonia in community and hospital patients 
Seven systematic reviews investigated the relationship between oral hygiene interventions and 
incidence of pneumonia in these patients, and all suggest there is good evidence that oral hygiene 
interventions (chlorhexidine, toothbrushing, professional oral care, povidone iodine) reduce the risk of 
pneumonia (28-33, 35).  The review quality ranged from high (16, 26, 28), which included a meta-
analysis, to moderate (31-33, 35). Two reviews suggest that there is a reduced risk of pneumonia with 
combined effect of mechanical and professional care (28, 33), and a third by Van der Maarel-Wierink 
et al.  (32) suggests that manual toothbrushing, with or without povidone iodine, reduced the risk of 
pneumonia in frail older people by 67%. Of note, while mechanical plaque removal was shown to 
reduce pneumonia incidence in non-ventilated patients, this result was not repeated for ventilated 
patients. 
 
In summary, there is good evidence that oral hygiene interventions reduce the risk of pneumonia in 
community and hospital patients. 
b) Outcomes of pneumonia 
Three high to moderate quality reviews found that mortality was reduced by mechanical plaque 
removal in community and hospital patients. (19, 28, 32). One high quality review by Silvestri et al. 
suggested no significant impact of chlorhexidine on pneumonia-associated mortality, although this 
paper included both ventilated and non-ventilated hospital patients (29). Kaneoka et al. (28), in a high 
quality review, suggest that there is moderate evidence from two randomised, controlled trials, that 
mechanical oral care can lead to a risk reduction in fatal pneumonia but highlight a need for caution 
due to a risk of possible bias in the included studies (19). Similarly, two studies included in the 
systematic review by Van der Maarel-Wierink et al. (32), found that toothbrushing without povidone 
iodine reduced pneumonia mortality (RR = 2.40 and 95% CI = 1.54–3.74 and OR = 3.57; 95% CI = 
1.13–13.70).   
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Two high quality reviews suggest that the number of febrile days may be reduced by implementing 
oral health interventions (17, 29). One review found that toothbrushing with 1% iodine, or scaling 
combined with electric toothbrushing led to a reduction in febrile days (30). These reviews do not 
include meta-analysis and should therefore be considered with caution. 
  
Use of topical antiseptics and professional oral health care both appear to reduce microbial 
colonisation of the oral cavity. In a high quality review, Silvestri et al. (29), report that chlorhexidine 
controls both gram-positive and gram-negative bacteria-related pneumonia as well as most (but not 
all) specific pneumonia-causing bacteria such as Streptococcus pneumoniae or Haemophilus 
influenza. However, when micro-organisms are classified into “normal” and “abnormal”, chlorhexidine 
significantly reduces pneumonia due to “normal” flora only (29).  One study in the review by Van der 
Maarel-Wierink et al. (32), suggests a reduction in levels of potential respiratory pathogens 
(Streptococci, Staphylococci, Candida, Pseudomonas, and Black-pigmented Bacteroides species) 
after weekly professional oral health care. Professional oral care being defined as mechanical 
cleaning by a dentist/hygienist which varied in frequency from one- to three-times weekly. 
   
A moderate quality review by Van der Maarel-Wierink et al., which examined known risk factors for 
aspiration pneumonia reported an improvement in four out of five risk factors (swallowing latency 
time, activities of daily living scale, swallowing reflex, cough reflex sensitivity; but not salivary 
substance P) associated with regular oral hygiene (32).  
 
In summary, good to moderate evidence suggests that oral hygiene interventions reduce many of the 
outcomes of pneumonia including febrile days, microbial colonisation, and mortality with the latter 
primarily being reduced by mechanical plaque removal. 
 
II] The effect of oral hygiene interventions on incidence and outcomes of pulmonary disease in 
ventilated patients 
There is a significant body of evidence relating to the effect of oral hygiene interventions on VAP, 
although no evidence regarding any other pulmonary disease. Again, this section focused on 
pneumonia as the pulmonary disease outcome. 
a) Incidence of VAP 
In mechanically ventilated patients there is strong evidence from 13 systematic reviews that use of 
chlorhexidine (gel or mouthwash), when used in concentrations varying from 0.12-2.0%, reduces the 
risk of incidence of VAP (14, 16-21, 24, 26, 27, 29-31). Only one moderate-quality study (25), the 
oldest included, did not find a significant reduction. The pooled relative risk of acquiring VAP reduced 
by approximately 40% when chlorhexidine-based oral decontamination was provided to ventilated 
patients in comparison to control groups (specifics of control groups varied among studies and 
included toothbrushing, “standard oral care”, placebo, other oral decontaminants, sterile water. Five 
reviews (two high, two moderate and one low quality) suggest the number needed to treat (NNT) as 
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between 8 and 21 (with the high quality reviews finding a NNT of 14 and 15); meaning that between 8 
and 21 ventilated patients in intensive care need to receive chlorhexidine oral decontamination for 
one case of VAP to be prevented (20, 22, 26, 27, 33). Mechanical toothbrushing in addition to the use 
of chlorhexidine was not found to reduce the incidence of VAP by three high quality, and one 
moderate quality reviews (14, 15, 20, 23). 
In summary, there is strong evidence that regular chlorhexidine use in ventilated patients reduces the 
risk of VAP; with no evidence to show that mechanical plaque removal in addition to chlorhexidine 
provides further benefit. 
b) Outcomes of VAP 
No significant effect on mortality, duration of mechanical ventilation or duration of hospital stay was 
demonstrated (14, 17-20, 22, 24-26), and no evidence was found of a difference between 
chlorhexidine and placebo for the outcomes of VAP and mortality in children (20). Other notable 
outcomes were that the use of chlorhexidine had a greater treatment effect in cardio-surgical patients 
(24, 29, 36), and authors postulated that this was related to the planned nature of the intubation and 
the physical status of the patient at the time. 
 
In relation to the impact of oral interventions on the use of systemic antibiotic therapy, Shi et al (20), a 
high quality review based on two randomised clinical trials, reported no significant difference in 
duration of antibiotic therapy, for the management of VAP, between intervention and control groups.  
One high quality systematic review, including four randomised-controlled trials, found no significant 
difference in antibiotic-free days between patients who received oral care and the control group (15). 
 
Four reviews (20, 23, 24, 30) high to medium quality include evidence regarding oral health indices, in 
particular plaque scores. El-Rabbany et al (30), in a high quality review suggest that toothbushing 
does improve oral health and has a positive effect on plaque scores when used on ventilated patients. 
It is suggested that this will reduce VAP, although as mentioned above, four reviews found 
toothbrushing had no effect.  They do clarify that the studies reviewed were of moderate to high risk of 
bias. Two reviews (23, 24), report lower plaque levels in chlorhexidine groups versus controls in five 
trials, while one trial showed no such difference.  
Shi et al (20), reported the effect on plaque scores for toothbrushing versus no brushing and the use 
of chlorhexidine plus brushing versus a control group with chlorhexidine alone. The studies were of 
moderate to high risk of bias and presented ambivalent conclusions, when compared. One study 
indicated that plaque scores were improved, whereas the other three showed no difference. 
In relation to microbial colonisation, Shi et al., found insufficient reliable and consistent evidence to 
confirm whether microbial colonisation of dental plaque varied between intervention and control 
groups for VAP (20).  On adverse effects of the interventions, two high and one moderate quality 
reviews (18, 20, 24), considered adverse effects in the evidence from the studies they included. One 
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study reported that three patients receiving chlorhexidine complained of a transient, unpleasant taste 
and this compared to five patients in the control arm of the study (20). In a further study, 9.8% of 
patients receiving chlorhexidine complained of mucosal irritation compared with 1% of the control 
group (20).  Snyder et al (18), concurred with the comments from this study but added that further 
instruction to staff to be more gentle, reduced the reports of irritation. Chlebicki et al. (24), reported no 
adverse effects.  
 
Adverse effects/side effects reported were transient in nature and were reported in relation to 
chlorhexidine intervention and the control groups. The adverse effects of chlorhexidine were not 
unexpected and are those described within the drug proprietary literature. There was no reported 
evidence on the effect of oral hygiene interventions on the number of febrile days for ventilated 
patients.  
 
In summary, there is moderate to low quality evidence that chlorhexidine does not have an effect on 
the following outcomes of VAP: mortality, duration of hospital stay, duration of ventilation, antibiotic 
use, plaque scores, microbial colonisation; or VAP in children. No unexpected side-effects of 
chlorhexidine were found. 
c) Cost-effectiveness 
Three systematic reviews reported on the cost-effectiveness of chlorhexidine as an oral care 
intervention (16, 18, 24). Where chlorhexidine reduced the incidence of VAP by 43%, the comparative 
cost of a year’s supply of chlorhexidine (Peridex) was less than 10% of the cost associated with a 
single case of VAP (16). The cost of chlorhexidine therapy for fourteen patients was suggested to be 
less than 10% of the cost of antibiotic therapy alone for one case of VAP (16).  
Snyders et al (18), also included two trials that considered the cost-effectiveness of chlorhexidine. 
Both suggested that chlorhexidine was cost-effective, and one suggested that the cost-effectiveness 
may be as much as ten times less per patient than the cost of antibiotics to treat VAP (18). Chlebicki 
et al. (24) quotes studies examining costs of chlorhexidine, but notes no formal cost-effective analysis 
was found. 
In summary, good evidence suggests that chlorhexidine is cost-effective when used to reduce 
pneumonia incidence. 
d) Other antimicrobial agents  
The effectiveness of topical application of povidone iodine for oral disinfection was considered in five 
systematic reviews of which four were high quality (16, 19, 27, 29). There is weak evidence that 
povidone iodine reduces the incidence of pneumonia, but this mode of oral disinfection was less 
effective than the use of chlorhexidine (17, 20, 28, 30, 32). 
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In summary, moderate evidence suggests both mechanical and chemical interventions have an 
impact on the incidence and outcomes of pneumonia in community and hospital patients. In regards 
to VAP, there is strong evidence that chemical interventions in general reduce incidence but do not 
affect other patient outcomes.  
Summary 
The cumulative evidence of this review suggests an association between oral and pulmonary disease, 
specifically COPD and pneumonia, and incidence of the latter can be reduced by oral hygiene measures 
such as chlorhexidine and povidone iodine in all patients, while toothbrushing reduces the incidence, 
duration, and mortality in community and hospital patients. 
This review has a number of strengths and limitations which should be recognised. First, the review 
process conducted by a multidisciplinary team containing medical, dental, and public health 
professionals allowed for broad input and feedback and was thus considered a strength. Second, this 
is a “rapid review”, and so was intended to summarise existing evidence, rather than undertake 
quantitative synthesis of evidence. Third, there was large heterogeneity in the methodology of the 
studies in the literature reviewed including: variations in oral care interventions, varying measures of 
the chemical interventions such as chlorhexidine, and varying definitions/diagnoses of oral and 
pulmonary diseases; none-the-less there is important learning to inform future research. 
The evidence has significant implications for research and services. First, the findings that highlight a 
reduction in the incidence of pneumonia in community and hospital patients after the implementation of 
oral hygiene measures (namely: toothbrushing, chlorhexidine, professional oral cleaning, and povidone 
iodine), provide useful data in planning for the oral health components of care pathways for patients 
with pneumonia.  Second, a number of reviews demonstrated a reduction in the incidence of pneumonia 
after both chlorhexidine use and toothbrushing in community and hospital patients; and some studies, 
with a high risk of bias, additionally suggested that toothbrushing reduced the duration (days of fever) 
and mortality of pneumonia. Overall this evidence supports the implementation of oral health protocols 
for pneumonia patients.  
There was a greater volume of evidence on the role of oral hygiene interventions in reducing the 
incidence of VAP. Chlorhexidine was shown to be effective in reducing the incidence of VAP which has 
implications for patient well-being, and cost-effective, without unexpected or severe adverse effects. In 
contrast to non-ventilated patients, toothbrushing alone had no effect on VAP incidence.  
There is a clear need for further research, particularly around the cost-effectiveness and feasibility of 
implementation of oral hygiene interventions and their outcomes, as part of the care pathway for 
community-living and hospitalised frail patients in particular (Table 2).  
Table 2  
Although chlorhexidine was found to reduce the incidence of pneumonia as outlined in the paragraph 
above; other outcomes related to VAP, such as mortality or duration of ventilation/hospital-stay, were 
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not affected by either chlorhexidine or toothbrushing. This seems contradictory and certainly warrants 
further investigation, especially as a low sample size and low attributable mortality of VAP may be the 
explanation (37). 
So what can and should clinicians caring for community, hospital and ventilated patients do while 
waiting for this research? Daily oral care is central to oral health for everyone. Numerous guidelines 
(38-40) recommend regular oral care in older people to prevent oral disease and maintain oral health. 
Alongside these benefits, patients, carers, and relatives should be informed that improved oral 
hygiene may prevent episodes of pneumonia, and has been shown in some studies to reduce the 
incidence of mortality. In order to maintain optimal oral health, mechanical plaque removal by twice-
daily toothbrushing is recommended (12), the preventative effects of oral hygiene for the reduction of 
pneumonia can be further augmented by the oral application of chlorhexidine mouthwash, gels or 
other forms of delivery.  
Where possible, this regimen can be carried out by the patient, and where not, a regular oral care 
plan should be created, implemented, and reviewed at regular intervals, either by or in consultation 
with a dental professional. To prevent and improve the outcomes of pneumonia, commissioners and 
managers of services are advised to provide oral hygiene training for carers.  Improving patients’, 
relatives’ and carers’ knowledge of the effects of poor oral health has the potential to support health 
maintenance in vulnerable patients, deliver cost-effective care, and improve patient quality of life. 
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Tables and Figures 
Figure 1 Search terms  
1. (pulmonary or respiratory or lung) and (disease$ or infection$ or condition$) (all fields) 
2. (pneumonia or respiratory tract infection or RTI) (all fields) 
3. (chronic obstructive pulmonary dis$ or COPD) (all fields) 
4. (dysphagia or aspirat$ or ventil$) (all fields) 
5. (pulmonary or lung or respiratory) and (cancer or neoplasm) (all fields) 
6. asthma or tuberculosis (all fields) 
7. (oral or dental) and (health or hygiene or disease$ or care or infection) (all fields) 
8. (periodon$ or gum) and disease (all fields) 
9. (caries or tooth decay or DMFT) (all fields) 
10. (plaque or oral bacteria or respiratory pathogen) (all fields) 
11. (toothbrush$ or tooth brush $ or chlorhexidine) (all fields) 
12. (systematic review) (all fields) 
13. (meta ana$ or meta-ana$) (all fields) 
Cochrane, PubMed, OVID (Embase, MEDLINE (R), PsycINFO) 
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Figure 2 Flow diagram 
 
PRISMA 2009 Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
  
Records identified through 
database searching 
(n =  272) 
Sc
re
e
n
in
g 
In
cl
u
d
ed
 
El
ig
ib
ili
ty
 
Id
e
n
ti
fi
ca
ti
o
n
 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 176) 
Records screened 
(n = 176 ) 
Records excluded 
(n = 141) 
Full-text articles assessed 
for eligibility 
(n = 35) 
Full-text articles excluded 
 No mention of oral health or  
any pulmonary disease 
 Not available in English 
 Full text not available after 
contacting authors 
 An updated, more recent 
review by the same author 
group exists 
(n = 12) 
Studies included in 
quantitative synthesis  
(n = 23) 
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Results 
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Azarpazh
ooh and 
Leake 
(2006) 
 
(34) 
Pneumonia: ICU, Outpatients 
Clinics, Nursing Homes. 
COPD: General population 
including Veterans in a 
longitudinal study with more 
focus on elderly. 
Reversibility: ICU, Nursing 
Homes, Hospital patients who 
required ventilation who were 
followed up until discharge. 
I]Caries  
II] Periodontal 
Disease. 
III] Use of 
Tooth 
Brushing, 
Topical 
Antiseptic, 
Topical 
Antimicrobial, 
Oral Care 
IV] Caries  
pathogens 
V] Periodontal 
pathogens 
Pneumonia:  
4 prospective 
cohort  
I] case-control.  
COPD: 2 
case-controls 
and II] cross-
sectional 
studies. 
Reversibility 
of 
pneumonia: 
10 Clinical 
Trials  
 
I] Association between pneumonia and oral health. Overall, potential risk 
factors for pneumonia were identified as the presence of cariogenic and 
periodontal pathogens in saliva and dental plaque (odds ratio [OR] = 4 to 
9.6) and dental decay (OR; 1.2 per decayed tooth). Higher plaque scores 
were also shown to be associated with a previous history of respiratory tract 
infection (RTI) (Caries and perio/cariogenic pathogens). 
 
II] Association between periodontal disease and COPD. One study 
Whole-mouth bone loss scores at baseline: RR = 1.6; 95% CI = 1.2 to 2.0. 2) 
ABL status at baseline was an independent risk factor for COPD, with 
subjects in the worst population quintile of bone loss (mean ABL >20% per 
site) found to be at a significantly higher risk (OR = 1.8; 95% CI = 1.3 to 
2.5).Three studies found a weak association (OR/relative risk [RR] <2.0) 
between COPD and oral health measures. 
 
III] Evidence of reversibility of pneumonia.  intervention methods for 
reducing the colonies of respiratory pathogens in the 
oral cavity decreased mortality and morbidity with 
levels of evidence of I to II-1. 
There is fair evidence of a link between 
pneumonia and oral health with an odds 
ratio of 1.2 to 9.6 depending on oral 
health indicators. There is good evidence 
that improved oral hygiene and frequent 
professional oral health care reduces the 
progression of pulmonary disease of high 
risk elderly adults living in nursing homes 
and in ICU. Except for one study, 46 all 
studies showed that interventions 
reduced the incidence of pneumonia 
and/or the length of mechanical 
ventilation. However, none of the studies 
measured a decrease in plaque by the 
end of the trials, leaving us in the dark as 
to whether the interventions worked 
through reducing plaque or some other 
means. 
Moderate 
(7/11). 
 
No conflict of 
interest 
stated, grey 
literature not 
searched, 
publication 
bias not 
addressed 
Shi et al 
(2013) 
 
(19) 
Critically ill patients receiving 
mechanical ventilation. 
I] CHX 
antiseptic 
mouth rinse or 
gel compared 
to treatment 
without the 
active 
ingredient 
chlorhexidine) 
or usual 
care, (with or 
without tooth 
brushing). 
35 RCTs I)Effect of intervention on incidence of VAP  
There is moderate quality evidence from 17/35 RCTs that the use of CHX 
(either as a mouth rinse or a gel) reduces the odds of developing VAP (OR 
0.60, 95% CI 0.47 to 0.77, P < 0.001, I2 = 21%) with an NNT of 15 (95% CI 
10 to 34). In children (3/35) OH with CHX does not show a statistically 
different reduction in VAP when compared with placebo.  
Weak evidence that povidone iodine rinse is more effective than saline in 
reducing VAP (OR 0.35, 95% CI 0.19 to 0.65, P = 0.0009, I2 = 53%) (two 
studies, 206 participants, high risk of bias). We found no evidence of a 
difference between a saline swab and a saline rinse with regard to the 
reduction of VAP (OR 0.65, 95% CI 0.37 to 1.14, P = 0.13, I2 = 41%) (two 
studies, 83 participants, high risk of bias), and very weak evidence that use 
of both a saline swab and a saline rinse may be more effective than a saline 
I] There is good evidence that effective 
OHC is important for ventilated patients 
in intensive care.  
II] OHC that includes either chlorhexidine 
mouthwash or gel is 
associated with a 40% reduction in the 
odds of developing VAP in critically ill 
adults.  
III] There is no 
evidence of a difference in the outcomes 
of mortality, duration of mechanical 
ventilation or duration of ICU stay. There 
is no evidence that OHC including both 
High (11/11) 
 
Fulfilled all 
AMSTAR 
criteria 
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II] Tooth 
brushing 
compared with 
no tooth 
brushing, (with 
or without 
chlorhexidine)  
III. Powered 
compared with 
manual tooth 
brushing. 
IV. Oral care 
with other 
solutions. 
swab alone (OR 0.30, 95% CI 0.14 to 0.63, P = 0.002, I2 = 0%) (two studies, 
40 participants, high risk of bias). 
 
II] Effect of intervention on mortality 
There is no significant evidence that use of CHX alone (15/35) or tooth 
brushing (with or without CHX) is associated with a significant difference in 
mortality. From 3/35 studies that included children there was no evidence of 
a difference between CHX and placebo for the outcomes of VAP and 
mortality (moderate quality evidence).       
                                                                                                                                                                                  
III] Duration of ICU stay and MV 
There is no significant evidence to suggest that OH interventions (CHX or 
tooth brushing) can reduce duration of MV or duration of ICU stay (moderate 
quality evidence). There is insufficient evidence to determine the effect of 
CHX on the other secondary outcomes.  
 
IV]The effect of tooth brushing on VAP incidence  
4/35 RCTs (low quality evidence) found no significant difference between 
oral care with CHX plus tooth brushing and oral care with CHX alone with 
regard to the outcome of VAP (OR 0.69, 95% CI 0.36 to 1.29, P = 0.24 , I2 = 
64%). (moderate quality evidence).     
There is insufficient evidence to determine the effects of powered versus 
manual tooth brushing on the incidence and outcomes of VAP. 
 
V] Systemic antibiotic therapy 
No reported significant difference in duration of antibiotic therapy between 
intervention and control groups (2/35).  
 
VI] Microbial colonisation 
Insufficient evidence to determine whether there is a difference in positive 
cultures between intervention and control groups (4/35). 
 
VI] Oral health indices 
No difference between CHX and control group plaque indices (2/35) 
 
VII] Adverse effects   
 3 patients receiving CHX complained of a transient unpleasant taste 
compared to five control patients. In a further study 9.8% of patients 
receiving CHX complained of mucosal irritation compared to 1% in the 
control group.(2/35) 
CHX and tooth brushing is different from 
OHC with CHX alone, and some weak 
evidence to suggest that povidone iodine 
mouth rinse is more effective than saline 
in reducing VAP. There is insufficient 
evidence to determine whether powered 
tooth brushing or other oral care 
solutions are effective in reducing VAP. 
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Kaneoka et 
al. (2015) 
(27) 
I] Nursing home residents 
(3/5) (of these 2/5 stable 
physical and cognitive 
function), mean age >80. 
II] Neuro-intensive care unit, 
mean age 36 (1/5). 
III] Rehabilitation unit mean 
age 69 (1/5). 
IV] Did not include participants 
at high risk of developing 
pneumonia e.g. NG tubes or 
severe dementia. 
I] CHX 0.2% 
rinse gargled 
BD (2/5) 
II]”Routine oral 
care” (3/5) 
III] 
"Professional 
oral care"  
(3/5) 
5 RCTs I] Incidence of pneumonia: 
Individually, 0/4 RCTs showed significant RR for oral care in preventing 
pneumonia in non-ventilated, but when combine din meta-analysis a 
significant preventative effect was found. Combined effect of mechanical oral 
care in combination with professional care significantly reduced the risk for 
non-VAP (RR, 0.61; 95% CI, 0.40–0.92; P=.02).  
 
II] Preventing fatal pneumonia 
Pooled RR from 2 RCTs for fatal pneumonia was significant (RR, 0.41; 95% 
CI, 0.23–0.71; P= .002) with no statistical heterogeneity (χ2= 0.94; df =1; P 
=.33; I2 =0%). Mechanical oral care significantly reduced the risk for fatal 
pneumonia in elderly nursing home residents.  
I] There is moderate evidence to suggest 
that non-VAP incidence is reduced when 
mechanical and professional oral care 
are combined.  
 
II] Moderate evidence that mechanical 
oral care can lead to a risk reduction in 
fatal pneumonia.  
 
III] Caution in interpretation due to risk of 
bias in the included trials. 
High (10/11) 
 
No list of 
excluded 
papers 
Vilela et al. 
(2015) 
 
(30) 
ICU: Mixed, trauma, surgical, 
general, respiratory.  
I]CHX 
0.12% 
solution,0.2% 
solution, 2% 
solution  
 
II] 
Adjuncts: 
i) TB,  
ii) sodium 
bicarbonate 
iii) colistin. 
13 RCTs , 1  
ECR  
I] Incidence of nosocomial pneumonia 
9/13 RCTs found topical CHX reduced incidence of 
NP. 4/9 RCTs did not find statistically 
significant differences among the groups. 1/9RCTs observed a delay in the 
establishment of NP.  
 
Fair evidence exists to suggest that  
the control of oral biofilm reduces the 
incidence of 
NP at concentrations of 0.12% and 
above. Though 0.2% appears to be the 
most effective. 
 
Moderate 
(6/11) 
 
No grey 
literature 
search, no list 
of excluded 
papers, no 
pooling of 
data, 
publication is 
not 
addressed, 
conflict of 
interest not 
stated. 
Silvestri et al. 
(2014) 
 
(28) 
ICU:  
Mixed medical/surgical (9/22) , 
trauma (2/22), surgical (2/22), 
respiratory (1/22),  
medical(1/22), neurology 
(1/22), 
cardiac surgery (3/22),  
paediatric cardiac surgery 
(1/22),  
paediatric ICU (2/22),  
 
I] CHX 
preparations 
0.12%, 0.2%, 
0.2% CHX 
solution, 
0.5% CHX 
ointment 
 
II]Adjuncts: 
TB, sodium 
bicarbonate 
 
 
  
22 RCTs I] Effects of CHX on NP  
Good evidence to suggest that CHX significantly reduces the number of 
critically-ill patients who develop NP (OR 0.66; 95% CI 0.51-0.85; P<0.001) 
and VAP (OR 0.68, 95% CI 0.53-0.87, P<0.01). The NNT was 23.85 (95% CI 
23.83-23.87).  The 
subgroup analysis reveals reduction in NP is significant only in surgical 
patients. 
 
II] Effect of CHX on oral bacteriome: Gram positive and gram negative  
bacteria   
Good evidence to suggest CHX reduced the incidence of pneumonia caused 
by gram positive (OR 0.41; 95% CI 0.19-0.85; P=0.02), and gram negative 
(OR 0.68; 95% CI 0.51-0.90; P<0.01) bacteria.  
 
I] Good evidence to suggest that CHX 
reduces NP and VAP in surgical patients.   
 
II] CHX controls NP due to both 
Gram-positive and Gram-negative 
bacteria.  
 
III] When micro-organisms are classified 
into “normal” 
and “abnormal”, CHX significantly 
reduces pneumonia due to “normal” flora 
only. Most, but not all, specific bacteria 
caused NP was reduced by CHX. 
High (10/11) 
 
No list of 
excluded 
papers 
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III] Effect of CHX on oral bacteriome: normal and abnormal bacteria. 
Good evidence to suggest that CHX significantly reduced NP due to "normal" 
micro-organisms (OR 0.51; 95% CI 0.33-0.80; P<0.01). No significant 
reduction seen in NP due to "abnormal" bacteria (OR 0.78; 95% CI 0.54-
1.21; P=0.16).  
 
III] Effect of CHX on mortality from pneumonia Non-significant, increase 
in the ORs for mortality in the CHX group (OR 1.11; 95% CI 0.92-1.33; 
P=0.28).  
 
IV] CHX shows no significant effect on 
mortality from pneumonia in the surgical, 
medical or paediatric population. 
El-Rabbany 
et al. (2015) 
 
(29) 
I] Adults  in hospital (25/28) 
ICU mean ages 32-62  
II] Adults in nursing home 
(2/28) mean age 82. 
III] Paediatric ICU (2/28) mean 
age 12 – 34.5 months. 
CHX, TB and 
OH, oral and 
pharyngeal 
suction, 
iodine, sodium 
bicarbonate, 
topical 
application of 
a non-
absorbable 
anti-biotic 
solution, 
professional 
oral health 
cleaning 
28 RCTs I] Effect of OH on pneumonia incidence 
Fair evidence exists to suggest a relationship between good oral care and 
lower rates of hospital acquired pneumonia.  
7/28 RCTs showed positive and significant effect. 12/28 RCTs showing no 
significant difference. TB was demonstrated to be effective in significantly 
reducing pneumonia incidence in RCTs. Professional oral health cleaning 
(1/28), antibiotic solution (1/28), and 10% povidone iodine (1/28) were shown 
to significantly reduce pneumonia rates.  
 
II] Febrile episodes from pneumonia 
2/28 RCTs showed a reduction in the number of cases of fever when using 
TB with 1% iodine or scaling with electric TB.  Both of these RCTs were in 
nursing home settings.  
 
III] Mortality associated with pneumonia.  
One short term study found that there were fewer deaths from pneumonia in 
in the intervention group.  
 
IV] Oral health indices 
Tooth brushing found to significantly reduce plaque levels (5/28) 
 
I] Fair evidence to suggest that OH is a 
viable method of reducing risk of Hap or 
VAP in both intensive and long-term care 
facilities. Conversely, evidence 
supporting the effectiveness of other oral 
care solutions that do not include CHX s 
still remains scarce and methodologically 
weak. 
II] Weak evidence exists to suggest a 
reduction in febrile days associated with 
pneumonia in nursing homes. 
 
II] There was heterogeneity between the 
studies (no meta-analysis was carried 
out in this paper) and as such results 
should be interpreted with caution.  
. 
High (9/11) 
 
 
No analysis of 
publication 
bias, no meta-
analysis. 
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Table 2: Key questions 
 
Key Questions to be addressed  
 Do oral hygiene interventions reverse oral diseases when 
incidence of pneumonia reduces? 
 Research is required in community settings  
 
 Does good regular oral hygiene (self-care, carers-care, 
professional-care) impact on risk of pulmonary disease? 
 As periodontal disease increases, does the risk of pulmonary 
disease increase? 
 Longitudinal research with cohorts of older adults required 
 What value do patients place on oral health care in frail states?  Anecdotally this depends on what value they placed on it 
before they were frail and the views of their carers. If they 
and their carers were aware of the importance of good oral 
hygiene (daily care), it may have wider health implications? 
 Is it cost-effective to implement oral hygiene interventions as part 
of care pathway of frail patients? 
 The costs and benefits associated with the management of 
pneumonia and repeated chest infections must be 
outweighed by the cost of maintaining oral hygiene 
 CHX is shown to be cost-effective in VAP, but there no 
evidence from community patients; hence, there is a need 
for more studies in community 
 What are the side effects of using chlorhexidine in vulnerable 
patients? 
 Depends on the presentation (mouthwash, gel) and mode of 
delivery (brush, swab, rinse) and the degree of frailty of 
patients which need to be identified in any future research 
 The irritant effect of CHX should be explored further 
 Other common side effects of CHX such as staining, altered 
taste, local hypersensitivity should be explored 
